Patents by Inventor Michael O'Neil

Michael O'Neil has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8524764
    Abstract: Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.
    Type: Grant
    Filed: January 14, 2011
    Date of Patent: September 3, 2013
    Assignee: Gilead Sciences, Inc.
    Inventors: Eda Canales, Lee S. Chong, Michael O' Neil Hanrahan Clarke, Edward Doerffler, Scott E. Lazerwith, Willard Lew, Michael Mertzman, Philip A. Morganelli, William J. Watkins
  • Patent number: 8513298
    Abstract: Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.
    Type: Grant
    Filed: January 14, 2011
    Date of Patent: August 20, 2013
    Assignee: Gilead Sciences, Inc.
    Inventors: Eda Canales, Michael O'Neil Hanrahan Clarke, Scott E. Lazerwith, Willard Lew, Philip Anthony Morganelli, William J. Watkins
  • Patent number: 8505296
    Abstract: A method for controlling engine temperature of an engine with a wide dynamic range is disclosed. In one example, the derivative of an engine temperature is assessed by a controller. The controller may adjust engine actuators to limit engine temperature in response to the derivative.
    Type: Grant
    Filed: September 13, 2012
    Date of Patent: August 13, 2013
    Assignee: Ford Global Technologies, LLC
    Inventors: Benjamin Carl Mukkala, Nathanael David Shaw, Jason Eugene Devries, Brian Michael O'Neil, Michael Joseph Giunta
  • Patent number: 8501714
    Abstract: Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.
    Type: Grant
    Filed: September 7, 2010
    Date of Patent: August 6, 2013
    Assignee: Gilead Sciences, Inc.
    Inventors: Aesop Cho, Lee S. Chong, Michael O'Neil Hanrahan Clarke, Edward Doerffler, Choung U. Kim, Qi Liu, William J. Watkins, Jennifer R. Zhang
  • Patent number: 8420597
    Abstract: The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
    Type: Grant
    Filed: August 29, 2012
    Date of Patent: April 16, 2013
    Assignee: Gilead Sciences, Inc.
    Inventors: Aesop Cho, Michael O'Neil Hanrahan Clarke, Choung U. Kim, John O. Link, Hyung-jung Pyun, Xiaoning C. Sheng, Qiaoyin Wu
  • Publication number: 20130053577
    Abstract: The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: August 29, 2012
    Publication date: February 28, 2013
    Applicant: Gilead Sciences, Inc.
    Inventors: Aesop Cho, Michael O' Neil Hanrahan Clarke, Choung U. Kim, John O. Link, Hyung-jung Pyun, Xiaoning C. Sheng, Qiaoyin Wu
  • Patent number: 8365730
    Abstract: Embodiments disclosed herein may include systems and methods for determining a patient's respiratory effort and blood oxygen saturation based on data acquired from a pulse oximetry sensor and analyzing the parameters in conjunction with each other. For example, the respiratory effort may be determined based on a photo-plethysmographic waveform generated from light attenuation detected by the sensor, and the blood oxygen saturation may be a pulse -based estimate of arterial blood oxygen saturation determined from the detected attenuation. Analysis of the parameters may enable detection and classification of apnea (e.g., obstructive or central) or another underlying cause for respiratory instability. Furthermore, the measured respiratory effort may be compared to respiratory effort supplied by a ventilator to ensure proper sensor placement before enabling automatic adjustment of ventilator settings.
    Type: Grant
    Filed: March 24, 2009
    Date of Patent: February 5, 2013
    Assignee: Covidien LP
    Inventors: Clark R. Baker, Jr., Michael O'Neil, Shannon Campbell, Gilbert Hausmann
  • Publication number: 20130006487
    Abstract: A method for controlling engine temperature of an engine with a wide dynamic range is disclosed. In one example, the derivative of an engine temperature is assessed by a controller. The controller may adjust engine actuators to limit engine temperature in response to the derivative.
    Type: Application
    Filed: September 13, 2012
    Publication date: January 3, 2013
    Applicant: FORD GLOBAL TECHNOLOGIES, LLC
    Inventors: Benjamin Carl Mukkala, Nathanael David Shaw, Jason Eugene Devries, Brian Michael O'Neil, Michael Joseph Guinta
  • Patent number: 8303465
    Abstract: A method for controlling engine temperature of an engine with a wide dynamic range is disclosed. In one example, the derivative of an engine temperature is assessed by a controller. The controller may adjust engine actuators to limit engine temperature in response to the derivative.
    Type: Grant
    Filed: October 30, 2009
    Date of Patent: November 6, 2012
    Assignee: Ford Global Technologies, LLC
    Inventors: Benjamin Carl Mukkala, Nathanael David Shaw, Jason Eugene Devries, Brian Michael O'Neil, Michael Joseph Guinta
  • Patent number: 8283442
    Abstract: The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: October 9, 2012
    Assignee: Gilead Sciences, Inc.
    Inventors: Aesop Cho, Michael O'Neil Hanrahan Clarke, Choung U. Kim, John O. Link, Hyung-jung Pyun, Xiaoning C. Sheng, Qiaoyin Wu
  • Publication number: 20120190866
    Abstract: The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
    Type: Application
    Filed: March 30, 2012
    Publication date: July 26, 2012
    Applicant: Gilead Sciences, Inc.
    Inventors: Aesop Cho, Michael O'Neil Hanrahan Clarke, Choung U. Kim, John O. Link, Hyung-jung Pyun, Xiaoning C. Sheng, Qiaoyin Wu
  • Publication number: 20120191197
    Abstract: A method of performing a procedure on an intervertebral disc includes inserting a cannulated delivery tube through an opening in an annulus fibrosus of the intervertebral disc, positioning an expandable portion of the tube within the opening in the annulus fibrosus, expanding the expandable portion into contact with the annulus fibrosus about the opening to create a seal between the expandable portion and the annulus fibrosus, performing a procedure through the cannulated delivery tube within the annulus fibrosis, removing the tube, and closing the opening in the annulus fibrosus.
    Type: Application
    Filed: April 3, 2012
    Publication date: July 26, 2012
    Inventors: Michael O'Neil, Christine Rusbarsky, J. Riley Hawkins
  • Publication number: 20120156166
    Abstract: Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.
    Type: Application
    Filed: September 7, 2010
    Publication date: June 21, 2012
    Applicant: Gilead Sciences, Inc.
    Inventors: Aesop Cho, Lee S. Chong, Michael O' Neil Hanrahan Clarke, Edward Doerffler, Choung U. Kim, Qi Liu, William J. Watkins, Jennifer R. Zhang
  • Patent number: 8197545
    Abstract: The invention provides a device and technique to seal an annular defect of an intervertebral disc, determine the in-situ volume of nucleus pulposus material removed, for example from a discectomy of a herniated disc, and facilitate injection of nuclear replacement material.
    Type: Grant
    Filed: October 27, 2005
    Date of Patent: June 12, 2012
    Assignee: DePuy Spine, Inc.
    Inventors: Michael O'Neil, Christine Rusbarsky, J. Riley Hawkins
  • Patent number: 8197513
    Abstract: A spinal implant including an at least one screw disposed within a wedge body is herein provided. The implant can be configured for placement with a facet joint in an intra-facet delivery. Furthermore, the implant can include a fusion-promoting bioactive material thereby providing a single device capable of spinal stabilization and/or fusion. Furthermore, a method of placing such an implant within a facet joint in an intra-facet orientation is hereby provided.
    Type: Grant
    Filed: April 13, 2007
    Date of Patent: June 12, 2012
    Assignee: DePuy Spine, Inc.
    Inventors: Michael Alan Fisher, Richard C. Techiera, Christopher Mickiewicz, Michael O'Neil
  • Patent number: 8178491
    Abstract: The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
    Type: Grant
    Filed: June 26, 2008
    Date of Patent: May 15, 2012
    Assignee: Gilead Sciences, Inc.
    Inventors: Aesop Cho, Michael O'Neil Hanrahan Clarke, Choung U. Kim, John O. Link, Hyung-jung Pyun, Xiaoning C. Sheng, Qiaoyin Wu
  • Publication number: 20120107274
    Abstract: Provided are methods for treating Orthomyxoviridae virus infections by administering ribosides, riboside phosphates and prodrugs thereof, of Formula I: wherein R2 is halogen. The compounds, compositions, and methods provided are particularly useful for the treatment of Human Influenza virus infections.
    Type: Application
    Filed: September 12, 2011
    Publication date: May 3, 2012
    Applicant: Gilead Sciences, Inc.
    Inventors: Michael O'Neil Hanrahan Clarke, Choung U. Kim, Willard Lew
  • Publication number: 20120010669
    Abstract: Spinal implants and methods for spinal stabilization and/or fusion are provided. Exemplary implants described herein can be configured for delivery to a facet joint to stabilize and/or fuse the facet joint, and can optionally be anchored within the pedicle for added fixation. The implant can optionally include a fusion-promoting bioactive material thereby providing a single device capable of spinal stabilization and/or fusion. Furthermore, a method of placing such an implant within a facet joint is provided.
    Type: Application
    Filed: July 12, 2010
    Publication date: January 12, 2012
    Applicant: DePuy Spine, Inc.
    Inventors: Michael O'Neil, John R. Hawkins, Michael A. Fisher, Robert M. Hart, Henri Defossez, Richard Fessler, Robert D. Labrom, Hassan A. Serhan, Duncan Betts, Shawn D. Stad
  • Publication number: 20120010662
    Abstract: Spinal implants and methods for spinal stabilization and/or fusion are provided. Exemplary implants described herein can be configured for delivery to a facet joint to stabilize and/or fuse the facet joint, and can optionally be anchored within the pedicle for added fixation. The implant can optionally include a fusion-promoting bioactive material thereby providing a single device capable of spinal stabilization and/or fusion. Furthermore, a method of placing such an implant within a facet joint is provided.
    Type: Application
    Filed: July 12, 2010
    Publication date: January 12, 2012
    Applicant: DePuy Spine, Inc.
    Inventors: Michael O'Neil, John R. Hawkins, Michael A. Fisher, Robert A. Hart, Richard Fessler, Robert D. LaBrom, Hassan A. Serhan, Shawn D. Stad
  • Publication number: 20110178058
    Abstract: Provided are compounds of Formula I: and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.
    Type: Application
    Filed: January 14, 2011
    Publication date: July 21, 2011
    Applicant: Gilead Sciences, Inc.
    Inventors: Eda CANALES, Lee S. Chong, Michael O' Neil Hanrahan Clarke, Edward Doerffler, Scott E. Lazerwith, Willard Lew, Michael Mertzman, Philip A. Morganelli, William J. Watkins